GERON CORP Loss Contingency, New Claims Filed, Number
GERON CORP (GERN) reported Loss Contingency, New Claims Filed, Number of 2 action for the 1-month period ending 2026-02-19, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Commitment and Contingencies › Loss Contingency, Quantities
us-gaap:LossContingencyNewClaimsFiledNumber · last filed 2026-08-05
- 2025-05-16: Loss Contingency, New Claims Filed, Number 1.00 lawsuit.
- 2025-04-16: Loss Contingency, New Claims Filed, Number 0 month 3.00 lawsuit.
- 2025-03-14: Loss Contingency, New Claims Filed, Number 0 month 2.00 lawsuit.
lawsuit
| Period end | Loss Contingency, New Claims Filed, Number | Loss Contingency, New Claims Filed, Number 0 month |
|---|---|---|
| 2025-05-16 | 1.00 lawsuit 10-Q · filed 2026-08-05 | |
| 2025-04-16 | 3.00 lawsuit 10-Q · filed 2026-08-05 | |
| 2025-03-14 | 2.00 lawsuit 10-Q · filed 2026-05-06 |
action
| Period end | Loss Contingency, New Claims Filed, Number | Loss Contingency, New Claims Filed, Number 1 month |
|---|---|---|
| 2026-02-19 | 2.00 action 10-Q · filed 2026-08-05 | |
| 2025-08-29 | 1.00 action 10-Q · filed 2026-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |